NCT02753400View on ClinicalTrials.gov

Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

December 31, 2017

Conditions
Proliferative Diabetic Retinopathy
Interventions
DRUG

emixustat hydrochloride

Tablet for oral administration

OTHER

Placebo

Placebo tablets for oral administration contain only inactive ingredients

Trial Locations (1)

Unknown

Retina Institute of California, Arcadia

Sponsors

Lead Sponsor

Kubota Vision Inc.
All Listed Sponsors
lead

Kubota Vision Inc.

INDUSTRY

NCT02753400 - Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy | Biotech Hunter | Biotech Hunter